Pacific Biosciences of California
PACB | NASDAQ
$1.84
-$0.12 (-6.12%)
At close: Nov 16, 2026, 4:00 PM ET
$1.84
$0.00 (+0.05%)
After-hours:
Nov 16, 2026, 7:42 PM ET
-6.12%
(1D)No price chart data available for 1D timeframe.
Rating
32.5
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #733/1021 (Top 72%)
Key Statistics
Market Data
Market Cap $574.52M
1D Range
1.82 1.91
52W Range
1.11 2.90
Valuation (TTM)
PE -4.38
PB -9.36
EV/EBITDA -9.00
Valuation (NTM)
Forward PE N/A
Forward PEG 0.06
Price Target $1.93
Cash Flow
FCF Yield -25.0%
SBC Adj. FCF Yield -30.5%
SBC Impact -22.2%
Margins
Gross Margin 34.5%
Operating Margin -99.6%
FCF Margin -88.8%
Growth (CAGR)
Revenue 3Y | 5Y -1.6% |
5.8%
Dil EPS 3Y | 5Y 43.6% |
11.7%
FCF 3Y | 5Y 28.1% |
17.3%
Returns
ROA -18.2%
ROE 604.2%
ROIC -24.5%
Financial Health
Net Debt
$445.71M
Current Ratio 4.62
Interest Coverage -38.57
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic c...
Sector Healthcare
Industry Medical - Devices
Employees 485
IPO Date Oct 27, 2010
Website www.pacb.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.11
Beat +18.23%
YoY:
+8.33% REV
$40.56M
Beat +3.19%
YoY:
+5.52%Next Earnings
Feb 9, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Hold
Price Target
$1.93
Upside
+4.89%
Buy (0)
Hold (2)
Sell (1)
Add to Watchlist
Select watchlists to add or remove PACB